Clinical Trial Update: Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPD [NA]

View source ↗

Summary

The study evaluating once-daily LAMA/LABA combinations versus tiotropium for constant-work-rate cycle endurance in COPD is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• LAMA/LABA combination
• tiotropium (tiotropium)

Snippet

Sponsor: Medical University of Bialystok | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | NA | Status: SUSPENDED